General Information of the Compound
Compound ID |
CP0182750
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
3-fluoro-5-[3-(5-fluoropyridin-2-yl)-1,2,4-oxadiazol-5-yl]benzonitrile
Show/Hide
|
||||||||||||||||||
Synonyms |
3-Fluoro-5-(3-(5-fluoropyridin-2-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
3-Fluoro-5-[3-(5-fluoro-2-pyridinyl)-1,2,4-oxadiazol-5-yl]benzonitrile
3-fluoro-5-[3-(5-fluoropyridin-2-yl)-1,2,4-oxadiazol-5-yl]benzonitrile
327056-26-8
54SQ9B412I
AKOS027470228
AZD 9272
AZD-9272
AZD9272
AZD9272, >
BDBM50395923
CHEMBL2164550
CHEMBL2164551
CS-0033119
GTPL6439
HY-110254
J3.560.338G
MolPort-039-338-067
RBSPCALDSNXWEP-UHFFFAOYSA-N
SCHEMBL2027395
UNII-54SQ9B412I
ZINC33980255
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C14H6F2N4O
|
||||||||||||||||||
Molecular Weight |
284.225
|
||||||||||||||||||
Canonical SMILES |
Fc1ccc(nc1)-c1noc(n1)-c1cc(F)cc(c1)C#N
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C14H6F2N4O/c15-10-1-2-12(18-7-10)13-19-14(21-20-13)9-3-8(6-17)4-11(16)5-9/h1-5,7H
Show/Hide
|
||||||||||||||||||
InChIKey |
RBSPCALDSNXWEP-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01247, Metabotropic glutamate receptor 5
Protein ID: PT00854, Metabotropic glutamate receptor 5
Clinical Information about the Compound